CORE Diagnostics to transition to Precipio’s price competitive ICE COLD-PCR™ platform NEW HAVEN, CT, (March [...]
Investors to convert preferred shares and exercise warrants NEW HAVEN, CT, (March 22nd, 2018) – Specialty [...]
Enhances competitive advantage as industry’s most cost effective solution NEW HAVEN, CT, (March 20th, 2018) – [...]
Completes Restructuring of close to 95% Transgenomic Liabilities NEW HAVEN, CT, (March 13th, 2018) – Specialty [...]
Strong indications of academic-level pathology market adoption and sales uptake NEW HAVEN, CT, (February 22nd, [...]
New test fulfills promise of liquid biopsies to cost effectively monitor patients NEW HAVEN, CT, [...]
First post-merger quarter to turn the corner and demonstrate growth NEW HAVEN, CT, (February 09th, [...]
First ICE-COLD PCR™ order generated from distribution partnership with Sowa Trading Company NEW HAVEN, CT, [...]
NEW HAVEN, CT, (January 22nd, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced it [...]
Sales growth acceleration plan to triple size of oncologist/hospital sales team in 2018 NEW HAVEN, [...]
No products in the cart.
Return to shop
Username or email address *
Remember me Log in
Lost your password?